UAB 1198: A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel with or without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer

Grant

Date/time Interval

  • February 1, 2015 - October 22, 2015
  • Awarded By

    Total Award Amount

  • 16356.00
  • Direct Costs

  • 12984.00
  • Sponsor Award Id

  • Contributor

  • Vaklavas M.D., Christos   Principal Investigator